TLSI - TriSalus Life Sciences, Inc.
5.2
0.060 1.154%
Share volume: 21,840
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$5.14
0.06
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 6.457 M | 7.364 M | 7.349 M | |
| Cost of revenue | 971.000 K | 912.000 K | 1.004 M | |
| Gross profit | 5.486 M | 6.452 M | 6.345 M | |
| 17.61% | -1.66% | |||
| Operating expenses | 10.484 M | 8.622 M | 8.946 M | |
| Selling general and admin | 4.627 M | 3.956 M | 4.727 M | |
| Research and development | 5.857 M | 4.666 M | 4.219 M | |
| Total expenses | 17.171 M | 14.626 M | 15.084 M | |
| -14.82% | 3.13% | |||
| Operating income | -11.685 M | -8.174 M | -8.739 M | |
| Ebit | -13.305 M | -3.545 M | -1.418 M | |
| Pretax income | -13.216 M | -4.325 M | -2.402 M | |
| -67.27% | -44.46% | |||
| Income tax | 3.000 K | 7.000 K | -3.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -13.219 M | -4.332 M | -2.399 M | |
| 67.23% | 44.62% |
